Delivery Order SPE2DB20D1100-SPE2DB25FE6K8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,723.61 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed-price, non-set-aside contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,786.65 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The place of...
- This delivery order, awarded August 29, 2025, grants AmerisourceBergen Drug Corp a $1,449.00 firm fixed price contract for Testosterone Cypionate 200 mg/mL, with completion scheduled for September 2, 2025. The award was issued by the Defense Logistics Agency under a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a $2,117.00 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on July 23, 2025, with completion expected by July 24, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The contract carries no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,130.17 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This contract, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $3,040.02 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a competitively awarded, firm fixed price contract with no set-aside designation. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $1,076.62 firm fixed price delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL, with an ultimate completion date of September 12, 2025. This non-set-aside contract represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's Medical Supply Chain...
- This delivery order, valued at $1,416.00, was awarded to AmerisourceBergen Drug Corp on August 5, 2025, by the Defense Logistics Agency (DLA) for the supply of Testosterone Cypionate 200 mg/mL. The contract is a firm fixed-price delivery order with performance scheduled to conclude on August 6, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. No set-aside designation was applied to this competitive...
- The Defense Logistics Agency awarded a delivery order valued at $1,942.58 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 1,000 mg/10 mL vials. This firm fixed price contract was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside, competitively awarded transaction and falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,569.66 for Testosterone Cypionate 200 mg/mL on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of pharmaceutical supply services to support federal medical procurement needs. The contract was not issued under any set-aside program and will be performed at the contractor's facility in Conshohocken,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE6K8Delivery Order
The Defense Logistics Agency awarded a $1,416 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order, awarded September 12, 2025, represents a non-competitive set-aside transaction and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that serves as the primary pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a critical position within the federal medical supply chain through its comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's DLA IDC vehicle enables it to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with diverse pharmaceutical products across multiple therapeutic domains. This testosterone cypionate delivery order exemplifies the routine fulfillment of hormone treatments and other specialty medications that constitute AmerisourceBergen's ongoing federal medical procurement responsibilities through its established prime vendor relationship.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/12/25 |